|

Olanzapine 2.5 MG Clinical Trials

2 actively recruiting trials

▼ -1 trial since July 2026

Also known as: OLN2.5

Pipeline

Phase 3: 2

Top Sponsors

  • Qinghai Red Cross Hospital1
  • Blokhin's Russian Cancer Research Center1

Indications

  • Cancer2
  • Oncology Patients Receiving Chemotherapy1
  • Olanzapine1
  • Cachexia-Anorexia Syndrome1
  • Progression-free Survival1

Other2 trials

Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy
Phase 3
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.